Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from China Isotope & Radiation Corp. ( (HK:1763) ).
China Isotope & Radiation Corporation has announced proposed further amendments to its Articles of Association, as well as the Rules of Procedures for both the Shareholders’ General Meeting and the Board. These amendments are in response to updates required by the Company Law of the People’s Republic of China and aim to align with regulatory policies and the company’s current situation. The proposed changes are subject to shareholder approval at the 2024 annual general meeting, and a circular detailing these amendments will be sent to shareholders.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on the production and application of isotopes and radiation technologies. The company provides a range of products and services including medical isotopes, radiopharmaceuticals, and radiation processing, catering primarily to healthcare and industrial sectors.
Average Trading Volume: 277,505
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.73B
Learn more about 1763 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue